Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 10-dihydro-10-deoxo-11-azaerythromycin A
2. Dd-azaerythromycin A
1. Azaerythromycin A
2. 76801-85-9
3. 6-demethylazithromycin
4. 9-deoxo-9a-aza-9a-homoerythromycin A
5. 4lsp9fjt5b
6. Azaerythromycin
7. Desmethyl Azithromycin
8. Dd-azaerythromycin A
9. Unii-4lsp9fjt5b
10. 9-deoxo-9a-aza-9a-homo Erythromycin A Desmethyl Azithromycin
11. Desmethyl
12. Desmethyl-azithromycin
13. Azithromycin Impurity A
14. (desmethyl Azithromycin)
15. 10-dihydro-10-deoxo-11-azaerythromycin A
16. Ec 616-385-9
17. Schembl6920246
18. Chembl1222181
19. Dtxsid30998123
20. Azaerythromycin A [usp-rs]
21. 2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-c-methyl-3-o-methylhexopyranoside
22. Mfcd09038719
23. S4978
24. Zinc94303232
25. Akos025401474
26. Ccg-270420
27. Cs-1474
28. 9-deoxo-9a-aza-9a-homo Erythromycin A
29. (2r,3s,4r,5r,8r,10r,11r,12s,13s,14r)-11-(4-dimethylamino-3-hydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-2-ethyl-3,4,10-trihydroxy-13-(5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yloxy)-3,5,8,10,12,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one
30. Ac-18936
31. Hy-17442
32. 6-demethylazithromycin (azaerythromycin A)
33. Azithromycin Impurity A [ep Impurity]
34. 801a859
35. Q27260028
36. (2r,3s,4r,5r,8r,10r,11r,12s,13s,14r)-11-(((2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-2-ethyl-3,4,10-trihydroxy-13-(((2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl)oxy)-3,5,8,10,12,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one
37. (2r,3s,4r,5r,8r,10r,11r,12s,13s,14r)-11-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,8,10,12,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one
38. (2r,3s,4r,5r,8r,10r,11r,12s,13s,14r)-11-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8
39. 1-oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-c-methyl-3-o-methyl-alpha-l-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-d-xylo-hexopyranosyl)oxy)-, (2r-(2r*,3s*,4r*,5r*,8r*,10r*,11r*,12s*,13s*,14r*))-
| Molecular Weight | 735.0 g/mol |
|---|---|
| Molecular Formula | C37H70N2O12 |
| XLogP3 | 3.6 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 7 |
| Exact Mass | 734.49287567 g/mol |
| Monoisotopic Mass | 734.49287567 g/mol |
| Topological Polar Surface Area | 189 Ų |
| Heavy Atom Count | 51 |
| Formal Charge | 0 |
| Complexity | 1120 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 18 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
USP
ABOUT THIS PAGE
A Azathramycin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Azathramycin, including repackagers and relabelers. The FDA regulates Azathramycin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Azathramycin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Azathramycin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Azathramycin supplier is an individual or a company that provides Azathramycin active pharmaceutical ingredient (API) or Azathramycin finished formulations upon request. The Azathramycin suppliers may include Azathramycin API manufacturers, exporters, distributors and traders.
click here to find a list of Azathramycin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Azathramycin DMF (Drug Master File) is a document detailing the whole manufacturing process of Azathramycin active pharmaceutical ingredient (API) in detail. Different forms of Azathramycin DMFs exist exist since differing nations have different regulations, such as Azathramycin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Azathramycin DMF submitted to regulatory agencies in the US is known as a USDMF. Azathramycin USDMF includes data on Azathramycin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Azathramycin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Azathramycin suppliers with USDMF on PharmaCompass.
Azathramycin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Azathramycin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Azathramycin GMP manufacturer or Azathramycin GMP API supplier for your needs.
A Azathramycin CoA (Certificate of Analysis) is a formal document that attests to Azathramycin's compliance with Azathramycin specifications and serves as a tool for batch-level quality control.
Azathramycin CoA mostly includes findings from lab analyses of a specific batch. For each Azathramycin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Azathramycin may be tested according to a variety of international standards, such as European Pharmacopoeia (Azathramycin EP), Azathramycin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Azathramycin USP).
LOOKING FOR A SUPPLIER?
